Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03847428
Brief Title: Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment (EMERALD-2)

First Submitted : February 18, 2019
First Submitted that Met QC Criteria : February 18, 2019
First Posted : February 20, 2019

Last Update Submitted that Met QC Criteria : January 27, 2021
Last Update Posted : January 28, 2021